Two tumour necrosis factor receptors: structure and function.

Tumour necrosis factor (TNF) exerts two main effects: a beneficial one as an anti-infection, anti-tumour cytokine, and a detrimental one in the systemic inflammatory response syndrome (SIRS). Two receptors (TNF-R) mediate these effects, but their precise role in different cell types is far from solved. TNF induces receptor oligomerization, an event that is believed to connect the receptors to downstream signalling pathways. Recent research suggests that several TNF-R-associated proteins, including kinases, may initiate cytoplasmic signal transduction.

[1]  C. Ware,et al.  TNF receptor signal transduction. Ligand-dependent stimulation of a serine protein kinase activity associated with (CD120a) TNFR60. , 1994, Journal of Immunology.

[2]  M. Boguski,et al.  A novel RING finger protein interacts with the cytoplasmic domain of CD40. , 1994, The Journal of biological chemistry.

[3]  H. Loetscher,et al.  Binding and regulation of cellular functions by monoclonal antibodies against human tumor necrosis factor receptors , 1990, The Journal of experimental medicine.

[4]  L. Tartaglia,et al.  A novel domain within the 55 kd TNF receptor signals cell death , 1993, Cell.

[5]  M. Gerhart,et al.  Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing , 1994, Nature.

[6]  S. Nagata,et al.  The Fas death factor , 1995, Science.

[7]  H. Loetscher,et al.  Tumor necrosis factor alpha (TNF-alpha)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55 , 1993, The Journal of experimental medicine.

[8]  S. Nagata,et al.  A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. , 1993, The Journal of biological chemistry.

[9]  F. Porteu,et al.  Tumor necrosis factor induces a selective shedding of its p75 receptor from human neutrophils. , 1994, The Journal of biological chemistry.

[10]  W. Schmiegel,et al.  Tumor necrosis factor (TNF) up-regulates the expression of p75 but not p55 TNF receptors, and both receptors mediate, independently of each other, up-regulation of transforming growth factor alpha and epidermal growth factor receptor mRNA. , 1993, The Journal of biological chemistry.

[11]  P. Vassalli,et al.  The pathophysiology of tumor necrosis factors. , 1992, Annual review of immunology.

[12]  W. Fiers,et al.  Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis , 1995, Nature.

[13]  Arul M. Chinnaiyan,et al.  FADD, a novel death domain-containing protein, interacts with the death domain of fas and initiates apoptosis , 1995, Cell.

[14]  K. Hsu,et al.  Differential expression and ligand binding properties of tumor necrosis factor receptor chimeric mutants. , 1993, The Journal of biological chemistry.

[15]  D. Goeddel,et al.  Monoclonal antibodies specific for murine p55 and p75 tumor necrosis factor receptors: identification of a novel in vivo role for p75 , 1995, The Journal of experimental medicine.

[16]  P. Vandenabeele,et al.  Human tumor necrosis factor mutants with preferential binding to and activity on either the R55 or R75 receptor. , 1994, European journal of biochemistry.

[17]  L. Tartaglia,et al.  Two TNF receptors. , 1992, Immunology today.

[18]  L. Gooding,et al.  A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact , 1990, Cell.

[19]  C. Belka,et al.  Tumor necrosis factor (TNF)‐alpha activates c‐raf‐1 kinase via the p55 TNF receptor engaging neutral sphingomyelinase. , 1995, The EMBO journal.

[20]  D. Wallach,et al.  Cytoplasmic truncation of the p55 tumour necrosis factor (TNF) receptor abolishes signalling, but not induced shedding of the receptor. , 1992, The EMBO journal.

[21]  H. Loetscher,et al.  Characterization of binding and biological effects of monoclonal antibodies against a human tumor necrosis factor receptor , 1990, The Journal of experimental medicine.

[22]  Sharad Kumar,et al.  ICE-like proteases in apoptosis. , 1995, Trends in biochemical sciences.

[23]  W. Fiers,et al.  Cytotoxicity in L929 murine fibrosarcoma cells after triggering of transfected human p75 tumour necrosis factor (TNF) receptor is mediated by endogenous murine TNF. , 1995, Cytokine.

[24]  W. Fiers,et al.  Tumor necrosis factor activates human endothelial cells through the p55 tumor necrosis factor receptor but the p75 receptor contributes to activation at low tumor necrosis factor concentration. , 1993, The American journal of pathology.

[25]  D. Goeddel,et al.  Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice , 1994, Nature.

[26]  J. Tavernier,et al.  Structure-activity studies of human tumour necrosis factors. , 1994, Protein engineering.

[27]  R. Gentz,et al.  Both tumor necrosis factor receptor types mediate proliferative signals in human mononuclear cell activation. , 1992, Journal of immunology.

[28]  W. Fiers.  Tumor necrosis factor Characterization at the molecular, cellular and in vivo level , 1991, FEBS letters.

[29]  D. Banner,et al.  Crystal structure of the soluble human 55 kd TNF receptor-human TNFβ complex: Implications for TNF receptor activation , 1993, Cell.

[30]  M. Krönke,et al.  Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling , 1994, Cell.

[31]  D. Goeddel,et al.  The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation , 1995, Cell.

[32]  R. Gentz,et al.  Two human TNF receptors have similar extracellular, but distinct intracellular, domain sequences. , 1990, Cytokine.

[33]  P. Scheurich,et al.  TR60 and TR80 tumor necrosis factor (TNF)-receptors can independently mediate cytolysis. , 1993, Lymphokine and cytokine research.

[34]  C. Ware,et al.  The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family , 1995, Cell.

[35]  D. Goeddel,et al.  A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor , 1994, Cell.

[36]  N. Fan,et al.  The p70 tumor necrosis factor receptor mediates cytotoxicity , 1992, Cell.

[37]  J. Darnell,et al.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. , 1994, Science.

[38]  W. Fiers,et al.  Endocytic pathway of recombinant murine tumor necrosis factor in L-929 cells. , 1988, Journal of immunology.

[39]  M. Tewari,et al.  Fas- and Tumor Necrosis Factor-induced Apoptosis Is Inhibited by the Poxvirus crmA Gene Product (*) , 1995, The Journal of Biological Chemistry.

[40]  S. Calvano,et al.  A human tumor necrosis factor (TNF) alpha mutant that binds exclusively to the p55 TNF receptor produces toxicity in the baboon , 1994, The Journal of experimental medicine.

[41]  M. Su,et al.  Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. , 1995, Science.

[42]  P. Vandenabeele,et al.  Generation and Biological Characterization of Membrane-bound, Uncleavable Murine Tumor Necrosis Factor (*) , 1995, The Journal of Biological Chemistry.

[43]  D. Donner,et al.  Aggregation of the intracellular domain of the type 1 tumor necrosis factor receptor defined by the two-hybrid system. , 1994, Journal of Biological Chemistry.

[44]  H. Steller.  Mechanisms and genes of cellular suicide , 1995, Science.

[45]  P. Leder,et al.  RIP: A novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death , 1995, Cell.

[46]  W. Fiers,et al.  Tumor necrosis factor : molecular and cellular biology and clinical relevance , 1993 .

[47]  W. Fiers,et al.  Both TNF receptors are required for TNF-mediated induction of apoptosis in PC60 cells. , 1995, Journal of immunology.

[48]  J. Camonis,et al.  Self-association of the Death Domains of the p55 Tumor Necrosis Factor (TNF) Receptor and Fas/APO1 Prompts Signaling for TNF and Fas/APO1 Effects (*) , 1995, The Journal of Biological Chemistry.

[49]  I. Beletsky,et al.  Dual role of the p75 tumor necrosis factor (TNF) receptor in TNF cytotoxicity , 1994, The Journal of experimental medicine.

[50]  J. Chant,et al.  GTPase cascades choreographing cellular behavior: Movement, morphogenesis, and more , 1995, Cell.

[51]  T. Mak,et al.  Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection , 1993, Cell.

[52]  S. Nagata,et al.  Involvement of an ICE-like protease in Fas-mediated apoptosis , 1995, Nature.

[53]  Yuan Zhang,et al.  Identification of a Protein with Homology to hsp90 That Binds the Type 1 Tumor Necrosis Factor Receptor (*) , 1995, The Journal of Biological Chemistry.

[54]  J. Cleveland,et al.  Contenders in FasL/TNF death signaling , 1995, Cell.

[55]  W. Fiers,et al.  Functional characterization of the human tumor necrosis factor receptor p75 in a transfected rat/mouse T cell hybridoma , 1992, The Journal of experimental medicine.

[56]  B. Aggarwal,et al.  Physical and functional association of a serine-threonine protein kinase to the cytoplasmic domain of the p80 form of the human tumor necrosis factor receptor in human histiocytic lymphoma U-937 cells. , 1994, The Journal of biological chemistry.

[57]  D. Goeddel,et al.  Biochemical properties of the 75-kDa tumor necrosis factor receptor. Characterization of ligand binding, internalization, and receptor phosphorylation. , 1992, The Journal of biological chemistry.

[58]  W. Fiers,et al.  Recombinant tumor necrosis factor: species specificity for a variety of human and murine transformed cell lines. , 1986, Cellular immunology.

[59]  V. Devita,et al.  Biologic Therapy of Cancer , 1992 .

[60]  Jan Tavernier,et al.  Human TNF mutants with selective activity on the p55 receptor , 1993, Nature.

[61]  William B. Smith,et al.  Dissociation of TNF‐alpha cytotoxic and proinflammatory activities by p55 receptor‐ and p75 receptor‐selective TNF‐alpha mutants. , 1994, The EMBO journal.

[62]  L. Tartaglia,et al.  Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. , 1993, The Journal of biological chemistry.

[63]  R. Zinkernagel,et al.  Mice lacking the tumour necrosis factor receptor 1 are resistant to IMF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes , 1993, Nature.

[64]  Muneesh Tewari,et al.  Yama/CPP32β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase , 1995, Cell.

[65]  R. Gentz,et al.  Genomic organization and promoter function of the murine tumor necrosis factor receptor β gene , 1993 .

[66]  W. Fiers,et al.  Molecular mechanisms of tumor necrosis factor‐induced cytotoxicity , 1994, FEBS letters.

[67]  B. Aggarwal,et al.  Identification of a protein kinase associated with the cytoplasmic domain of the p60 tumor necrosis factor receptor. , 1994, The Journal of biological chemistry.

[68]  C. Perez,et al.  A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: Ramifications for the complex physiology of TNF , 1988, Cell.

[69]  D. Banner,et al.  Human tumor necrosis factor alpha (TNF alpha) mutants with exclusive specificity for the 55-kDa or 75-kDa TNF receptors. , 1993, The Journal of biological chemistry.

[70]  D. Baltimore,et al.  Involvement of CRAF1, a relative of TRAF, in CD40 signaling , 1995, Science.

[71]  U. Gullberg,et al.  Modulation of the constitutive gene expression of the 55 kD tumor necrosis factor receptor in hematopoietic cells. , 1990, Biochemical and biophysical research communications.

[72]  B. Beutler,et al.  Unraveling function in the TNF ligand and receptor families. , 1994, Science.

[73]  J. Tainer,et al.  Transferrin receptor internalization sequence YXRF implicates a tight turn as the structural recognition motif for endocytosis , 1990, Cell.

[74]  M. Tewari,et al.  The Baculovirus p35 Protein Inhibits Fas- and Tumor Necrosis Factor-induced Apoptosis (*) , 1995, The Journal of Biological Chemistry.